Louis Yang, MS（楊錦宇）
Novartis Institutes for Biomedical Research
Louis Yang received his master degree training in Biochemistry at Argonne National Laboratory and Illinois Institute of Technology in Chicago, IL. He then joined the Dana-Farber Cancer Institute in Boston, MA as a research associate in the crystallography group, where he conducted and managed a large-scale protein expression and purification platform to support understanding of protein structure as it pertained to anti-cancer drug development. He then became a senior research associate at Synta Pharmaceuticals, where he was responsible for target discovery and validation of anti-cancer drugs. In 2009, he joined Novartis Institutes for Biomedical Research in the Ophthalmology group. As a Scientist II at Novartis, his responsibilities include drug screening (small molecules and antibody-drug conjugates) and collaboration with chemistry, DMPK, in vivo groups and outsourcing companies to develop innovative therapies for eye diseases. Louis grew up in Taipei and received his B.S. degree in Biology from Tunghai University in Taiwan.